These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19538487)

  • 1. Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection.
    Diaz JA; Booth AJ; Lu G; Wood SC; Pinsky DJ; Bishop DK
    Am J Transplant; 2009 Aug; 9(8):1773-83. PubMed ID: 19538487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis.
    Booth AJ; Wood SC; Cornett AM; Dreffs AA; Lu G; Muro AF; White ES; Bishop DK
    J Pathol; 2012 Mar; 226(4):609-18. PubMed ID: 21960174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection.
    Faust SM; Lu G; Marini BL; Zou W; Gordon D; Iwakura Y; Laouar Y; Bishop DK
    J Immunol; 2009 Dec; 183(11):7297-306. PubMed ID: 19917689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
    Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM
    Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 promotes cardiac graft rejection mediated by CD4+ cells.
    Booth AJ; Grabauskiene S; Wood SC; Lu G; Burrell BE; Bishop DK
    J Immunol; 2011 Dec; 187(11):5764-71. PubMed ID: 22025555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection.
    Bergese SD; Huang EH; Pelletier RP; Widmer MB; Ferguson RM; Orosz CG
    Am J Pathol; 1995 Jul; 147(1):166-75. PubMed ID: 7541609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection.
    Faust SM; Lu G; Wood SC; Bishop DK
    J Immunol; 2009 Dec; 183(11):7307-13. PubMed ID: 19917705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-3 Triggers Chronic Rejection of Cardiac Allografts by Activation of Infiltrating Basophils.
    Balam S; Schiechl-Brachner G; Buchtler S; Halbritter D; Schmidbauer K; Talke Y; Neumayer S; Salewski JN; Winter F; Karasuyama H; Yamanishi Y; Renner K; Geissler EK; Mack M
    J Immunol; 2019 Jun; 202(12):3514-3523. PubMed ID: 31068389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-interleukin-12/23p40 antibody attenuates chronic rejection of cardiac allografts partly via inhibition γδT cells.
    Wang S; Xu X; Xie A; Li J; Ye P; Liu Z; Wu J; Rui L; Xia J
    Clin Exp Immunol; 2012 Sep; 169(3):320-9. PubMed ID: 22861372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection.
    Chen X; Zhao S; Tang X; Ge H; Liu P
    Mol Vis; 2011; 17():2148-56. PubMed ID: 21850190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion.
    Itoh S; Kimura N; Axtell RC; Velotta JB; Gong Y; Wang X; Kajiwara N; Nambu A; Shimura E; Adachi H; Iwakura Y; Saito H; Okumura K; Sudo K; Steinman L; Robbins RC; Nakae S; Fischbein MP
    Circulation; 2011 Sep; 124(11 Suppl):S187-96. PubMed ID: 21911812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection.
    Booth AJ; Bishop DK
    Immunotherapy; 2010 Jul; 2(4):511-20. PubMed ID: 20636005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of IL-6/IL-6R Signaling Attenuates Acute Antibody-Mediated Rejection in a Mouse Cardiac Transplantation Model.
    Ma M; Sun Q; Li X; Deng G; Zhang Y; Yang Z; Han F; Huang Z; Fang Y; Liao T; Sun Q
    Front Immunol; 2021; 12():778359. PubMed ID: 34777394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.
    Lei J; He F; Wu M; Zheng X; Chen X; Chen Z
    Transpl Int; 2010 Dec; 23(12):1271-81. PubMed ID: 20646257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.
    Piccotti JR; Chan SY; Goodman RE; Magram J; Eichwald EJ; Bishop DK
    J Immunol; 1996 Sep; 157(5):1951-7. PubMed ID: 8757314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.